Cargando…

Nutrition and the Risk of Alzheimer's Disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that accounts for the major cause of dementia, and the increasing worldwide prevalence of AD is a major public health concern. Increasing epidemiological studies suggest that diet and nutrition might be important modifiable ri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Nan, Yu, Jin-Tai, Tan, Lin, Wang, Ying-Li, Sun, Lei, Tan, Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705810/ https://www.ncbi.nlm.nih.gov/pubmed/23865055 http://dx.doi.org/10.1155/2013/524820

Ejemplares similares

Behavioral and Psychological Symptoms in Alzheimer's Disease
por: Li, Xiao-Ling, et al.
Publicado: (2014)

Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han Chinese
por: Wang, Ying-Li, et al.
Publicado: (2013)

Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
por: Wang, Xiang-Xiang, et al.
Publicado: (2014)

Resveratrol as a Therapeutic Agent for Alzheimer's Disease
por: Ma, Teng, et al.
Publicado: (2014)

Heat Shock Protein 70 in Alzheimer's Disease
por: Lu, Rui-Chun, et al.
Publicado: (2014)

Heat Shock Protein 90 in Alzheimer's Disease
por: Ou, Jiang-Rong, et al.
Publicado: (2014)

Heat Shock Proteins at the Crossroads between Cancer and Alzheimer's Disease
por: Wang, Hao, et al.
Publicado: (2014)

TREML2 Mutation Mediate Alzheimer’s Disease Risk by Altering Neuronal Degeneration
por: Song, Ya-Nan, et al.
Publicado: (2019)

Microglia in Alzheimer's Disease
por: Li, Ying, et al.
Publicado: (2014)

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration
por: Tan, Meng-Shan, et al.
Publicado: (2021)

NME8 rs2718058 polymorphism with Alzheimer's disease risk: a replication and meta-analysis
por: Liu, Shu-Lei, et al.
Publicado: (2016)

Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts
por: Cao, Lei, et al.
Publicado: (2016)

FERMT2 rs17125944 polymorphism with Alzheimer's disease risk: a replication and meta-analysis
por: Zhang, Qiu-Yue, et al.
Publicado: (2016)

Multipredictor risk models for predicting individual risk of Alzheimer’s disease
por: Hou, Xiao-He, et al.
Publicado: (2023)

Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease
por: Wang, Wen-Ying, et al.
Publicado: (2015)

Genetically determined blood pressure, antihypertensive medications, and risk of Alzheimer’s disease: a Mendelian randomization study
por: Ou, Ya-Nan, et al.
Publicado: (2021)

MS4A6A genotypes are associated with the atrophy rates of Alzheimer's disease related brain structures
por: Ma, Jing, et al.
Publicado: (2016)

Association of cerebrospinal fluid neurogranin levels with cognition and neurodegeneration in Alzheimer’s disease
por: Xue, Mei, et al.
Publicado: (2020)

Metabolically healthy obesity reduces the risk of Alzheimer’s disease in elders: a longitudinal study
por: Ma, Ling-Zhi, et al.
Publicado: (2019)

Association between methylation of BIN1 promoter in peripheral blood and preclinical Alzheimer’s disease
por: Hu, Hao, et al.
Publicado: (2021)

Association of HMGCR polymorphism with late-onset Alzheimer's disease in Han Chinese
por: Chang, Xiao-Long, et al.
Publicado: (2016)

Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease
por: Wang, Chong, et al.
Publicado: (2014)

Association between Life’s Simple 7 and cerebrospinal fluid biomarkers of Alzheimer’s disease pathology in cognitively intact adults: the CABLE study
por: Zhao, Yong-Li, et al.
Publicado: (2022)

High pulse pressure is a risk factor for prodromal Alzheimer’s disease: a longitudinal study
por: Shi, Wen-Yan, et al.
Publicado: (2020)

Effect of CLU genetic variants on cerebrospinal fluid and neuroimaging markers in healthy, mild cognitive impairment and Alzheimer’s disease cohorts
por: Tan, Lin, et al.
Publicado: (2016)

Longitudinal plasma phosphorylated tau 181 tracks disease progression in Alzheimer’s disease
por: Chen, Shi-Dong, et al.
Publicado: (2021)

Nutritional intervention for diabetes mellitus with Alzheimer's disease
por: Li, Zhi, et al.
Publicado: (2022)

Association of peripheral immunity with cognition, neuroimaging, and Alzheimer’s pathology
por: Hou, Jia-Hui, et al.
Publicado: (2022)

Fasting blood glucose and cerebrospinal fluid Alzheimer’s biomarkers in non-diabetic cognitively normal elders: the CABLE study
por: Ou, Ya-Nan, et al.
Publicado: (2020)

Diabetes and Alzheimer's Disease: Mechanisms and Nutritional Aspects
por: Lee, Hee Jae, et al.
Publicado: (2018)

Disease trajectories in elders with suspected non-Alzheimer’s pathophysiology and its comparison with Alzheimer’s disease pathophysiology: a longitudinal study
por: Li, Jie-Qiong, et al.
Publicado: (2023)

Clinical and biomarker trajectories in sporadic Alzheimer's disease: A longitudinal study
por: Wang, Hui‐Fu, et al.
Publicado: (2020)

Association of rs2072446 in the NGFR gene with the risk of Alzheimer's disease and amyloid‐β deposition in the brain
por: He, Chen‐Yang, et al.
Publicado: (2022)

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
por: Wang, Zhi-Bo, et al.
Publicado: (2022)

Associations of the cerebrospinal fluid hepatocyte growth factor with Alzheimer’s disease pathology and cognitive function
por: Zhao, Li-Jing, et al.
Publicado: (2021)

The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer’s Disease: Exploring Interactions With Sex
por: Liu, Ying, et al.
Publicado: (2021)

Toll-like receptor 2 -196 to -174 del polymorphism influences the susceptibility of Han Chinese people to Alzheimer's disease
por: Yu, Jin-Tai, et al.
Publicado: (2011)

Association between NME8 Locus Polymorphism and Cognitive Decline, Cerebrospinal Fluid and Neuroimaging Biomarkers in Alzheimer's Disease
por: Liu, Ying, et al.
Publicado: (2014)

Discordant Alzheimer's neurodegenerative biomarkers and their clinical outcomes
por: Guo, Yu, et al.
Publicado: (2020)

ZCWPW1 is associated with late-onset Alzheimer's disease in Han Chinese: a replication study and meta-analyses
por: Gao, Yu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_sto0cb8jrn02lg7hnr8joqmgnt